Project Grant R42HG013908
Award Date
9/19/24
Completion Date
8/31/25
Dollars Obligated
$292K
Federal Agency
National Human Genome Research Institute
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
This $193,818 Cooperative Agreement award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) will support a project titled "Making Genomic Medicine Routine in a Rural Healthcare System." The project aims to address challenges in integrating genomic data into electronic health records and expanding access to genomic medicine expertise in rural communities. The primary awardee, Geisinger Clinic, will collaborate with the Genomic-Enabled Learning...
The National Human Genome Research Institute (NHGRI) awarded a $446,042 Project Grant (CFDA 93.172 - Human Genome Research) to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to develop a novel, web-based application called "NEST" that will empower families to understand and obtain appropriate follow-up care for infants diagnosed with rare genetic conditions. The key products and services to be delivered under this 3-year grant include: 1) Refining...
This federal Project Grant award from the National Human Genome Research Institute (NHGRI), under the Human Genome Research program (CFDA 93.172), provides $3,834,112 to Boston Children's Hospital to develop and refine computational tools to advance the safety and efficacy of genome editing. The key products and services to be delivered include: Enhancing the CRISPRME tool to better predict off-target effects of genome editing across diverse human genomes, and developing a new tool called...
This federal Project Grant award of $370,716 from the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172) aims to develop and test an implementation guide to facilitate the equitable integration of population-wide genomic screening (PGS) programs across diverse populations and settings. The Medical University of South Carolina (MUSC) is the primary awardee and will lead this 5-year project to: 1) conduct a qualitative needs assessment of 10...
This federal Project Grant award from the National Human Genome Research Institute (NHGRI), under the Human Genome Research program (CFDA 93.172), provides $1,033,069.24 to The Johns Hopkins University to develop novel statistical methods for data integration and analysis of genome-wide association studies (GWAS). The project aims to address challenges in incorporating diverse risk factors, including genetic markers, biomarkers, lifestyle factors, and sociodemographic indicators, from...
This $716,587 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) aims to advance equity in rare disease genomic research. The award will fund a hybrid effectiveness-implementation study at Boston Children's Hospital to develop and implement a Diversity, Equity, and Inclusion Toolkit for the Broad Institute's Rare Genomes Project. The study will evaluate the toolkit's impact on recruiting and retaining 200 participants from historically...
The National Human Genome Research Institute (NHGRI) awarded a $579,698 Project Grant (CFDA 93.172 - Human Genome Research) to the Fred Hutchinson Cancer Center in Seattle, WA. The "FACETING GEMS (GENOMICS EDUCATION MODULES) FOR THE ENTRY-LEVEL WORKFORCE" project aims to address the growing demand for genomics skills in the workforce by providing accessible, research-focused genomics training modules for community college faculty and students. Key objectives include: (1) developing...
This $400,000 Project Grant award from the National Human Genome Research Institute (NHGRI) under CFDA 93.172 "Human Genome Research" will support a research program at Brigham & Women's Hospital to develop advanced computational methods for accurately identifying and genotyping structural variants within large genetic biobank datasets. The key objectives of the work are to: 1) create haplotype-informed algorithms to improve detection sensitivity and genotyping accuracy for...
This federal Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $383,748 to Jumpcode Genomics Inc. to develop a CRISPR-based depletion technology to improve the accuracy of next-generation sequencing (NGS) for newborn screening clinical tests. The project aims to computationally design CRISPR guide RNAs and optimize protocols to deplete pseudogene-derived molecules from NGS libraries, which can lead to false-positive variant...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research CFDA Program (93.172), awarded Galatea Bio Inc. a $399,156 Project Grant (R43HG013628) on September 19, 2024 with a completion date of August 31, 2025. The grant funding supports the development and application of machine learning-based approaches for estimating disease risk in diverse and admixed populations. Key objectives include: 1) evaluating the performance of existing polygenic risk score (PRS) models...